tiprankstipranks
Advertisement
Advertisement
Quoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch
PremiumCompany AnnouncementsQuoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch
2M ago
Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays
Premium
Company Announcements
Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays
3M ago
Quoin Pharmaceuticals price target raised to $35 from $25 at Alliance Global
Premium
The Fly
Quoin Pharmaceuticals price target raised to $35 from $25 at Alliance Global
3M ago
Quoin Pharmaceuticals receives U.S. Fast Track Designation to QRX003
PremiumThe FlyQuoin Pharmaceuticals receives U.S. Fast Track Designation to QRX003
3M ago
QNRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
QNRX Earnings this Week: How Will it Perform?
3M ago
Quoin Pharmaceuticals highlights continued growth of NETHERTON NOW program
Premium
The Fly
Quoin Pharmaceuticals highlights continued growth of NETHERTON NOW program
4M ago
Quoin files Breakthrough Medicine Designation with SFDA for QRX003
PremiumThe FlyQuoin files Breakthrough Medicine Designation with SFDA for QRX003
5M ago
Quoin Pharmaceuticals Approves New Stock Option Agreements
Premium
Company Announcements
Quoin Pharmaceuticals Approves New Stock Option Agreements
7M ago
Promising Prospects for Quoin Pharmaceuticals: Buy Rating Backed by Innovative Developments and Pipeline Diversification
Premium
Ratings
Promising Prospects for Quoin Pharmaceuticals: Buy Rating Backed by Innovative Developments and Pipeline Diversification
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100